HIV reservoir in HIV patients

Por E. I. Veselova, G. D. Kaminskiy, A. G. Samoylova, I. A. Vasilyeva
Publicado em 2019-05-01

MUTATIONS OF MYCOBACTERIUM TUBERCULOSIS CAUSING RESISTANCE TO RIFAMPICIN AND ISONIAZID IN THE PATIENTS WITH DIFFERENT HIV STATUS

Por E. I. Veselova, A. E. Panova, G. D. Kaminskiy, A. G. Samoylova
Publicado em 2019-02-01

THE ANTI-TUBERCULOSIS ANTIBIOTIC OF RIFAPENTINE: PERSPECTIVES OF CLINICAL USE

Por A. G. Samoylova, E. I. Veselova, O. V. Lovacheva, G. D. Kaminsky
Publicado em 2019-01-01

Clinical and laboratory differences in patients with local and generalized forms of Kaposi sarcoma

Por V. D. Renev, E. V. Karamov, E. I. Veselova, O. V. Lovacheva, T. E. Tyulkova, G. D. Kaminskiy
Publicado em 2020-09-01

The use of different formulations of tocilizumab in the treatment of patients with moderate to severe COVID-19

Por E. I. Veselova, G. D. Kaminskiy, O. V. Lovacheva, B. A. Nanaeva, R. I. Romanov, А. V. Veselov
Publicado em 2021-02-01

Novel coronavirus infection

Por E. I. Veselova, A. E. Russkikh, G. D. Kaminskiy, O. V. Lovacheva, A. G. Samoylova, I. A. Vasilyeva
Publicado em 2020-05-01

Virological and immunological efficacy of metabolically favorable antiretroviral therapy regimens in HIV patients who had no previous treatment

Por E. I. Veselova, K. A. Kocharyan, O. V. Lovacheva, G. D. Kaminskiy, A. G. Samoylova, I. A. Vasilyeva
Publicado em 2020-06-01

Physics basis for the first ITER tungsten divertor

Por R.A. Pitts, X. Bonnin, F. Escourbiac, H. Frerichs, J.P. Gunn, T. Hirai, A.S. Kukushkin, E. Kaveeva, M.A. Miller, D. Moulton, V. Rozhansky, I. Senichenkov, E. Sytova, O. Schmitz, P.C. Stangeby, G. De Temmerman, I. Veselova, S. Wiesen
Publicado em 2019-08-01